Europe Clinical Trials Market 2021-2031

Bonafide Trust 03-04-2022 142 Pages
Region : Europe Category : Lifescience Medical Devices

Highend Report

Highend report of this product is available

View

New Report Guarantee

If you purchase this report now and we update it in new 100 days, get it free!

Report Description
Table of Contents
List of Figure Tables

Europe clinical trials market was valued at $10,471.1 million in 2021 and will grow by 6.2% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 39 tables and 79 figures, this 142-page report “Europe Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country. Based on Product Category, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Trials of Drugs o Small Molecule Drugs o Vaccines o Cell & Gene Therapy o Other Drugs • Trials of Devices • Trials of Procedures Based on Phase, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Phase I • Phase II • Phase III • Phase IV By Design, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Interventional Studies o Randomized Control Trial o Adaptive Clinical Trial o Non-randomized Control Trial • Observational Studies o Cohort Study o Case Control Study o Cross Sectional Study o Ecological Study • Expanded Access Trials By Service Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Protocol Designing • Site Identification • Patient Recruitment • Laboratory Services • Bioanalytical Testing Services • Clinical Trial Data Management Services • Clinical Trial Supply & Logistic Services • Decentralized Clinical Trial Services • Medical Device Testing Services • Other Clinical Trial Services By Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Infectious Diseases • Cardiology • Obesity • Diabetes • Neurology • Immunology • Pain Management • Other Indications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical and Biotechnological Companies • Clinical Research Organizations • Clinical Testing Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Phase, Design, and Indication over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Accell Clinical Research LLC Charles River Laboratory ClinDatrix Inc Clinipace Eli Lilly and Company F. Hoffmann-La Roche Ltd. ICON PLC IQVIA Holdings, Inc. Laboratory Corporation of America Novo Nordisk AS PAREXEL International Corporation Pfizer Inc. Pharmaceutical Product Development LLC PRA Health Sciences Sanofi SA SGS SA Syneos Health Inc. Wuxi AppTec Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 19

2.1 Market Size and Forecast 19

2.1.1 Impact of COVID-19 on World Economy 21

2.1.2 Impact of COVID-19 on the Market 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 32

2.4 Emerging Opportunities and Market Trends 35

2.5 Porter’s Fiver Forces Analysis 39

3 Segmentation of Europe Market by Product Category 43

3.1 Market Overview by Product Category 43

3.2 Trials of Drugs 45

3.2.1 Small Molecule Drugs 46

3.2.2 Vaccines 47

3.2.3 Cell & Gene Therapy 48

3.2.4 Other Drugs 49

3.3 Trials of Devices 50

3.4 Trials of Procedures 51

4 Segmentation of Europe Market by Phase 52

4.1 Market Overview by Phase 52

4.2 Phase I 54

4.3 Phase II 55

4.4 Phase III 56

4.5 Phase IV 57

5 Segmentation of Europe Market by Design 58

5.1 Market Overview by Design 58

5.2 Interventional Studies 60

5.2.1 Randomized Control Trial 62

5.2.2 Adaptive Clinical Trial 63

5.2.3 Non-randomized Control Trial 64

5.3 Observational Studies 65

5.3.1 Cohort Study 67

5.3.2 Case Control Study 68

5.3.3 Cross Sectional Study 69

5.3.4 Ecological Study 70

5.4 Expanded Access Trials 71

6 Segmentation of Europe Market by Service Type 72

6.1 Market Overview by Service Type 72

6.2 Protocol Designing 74

6.3 Site Identification 75

6.4 Patient Recruitment 76

6.5 Laboratory Services 77

6.6 Bioanalytical Testing Services 78

6.7 Clinical Trial Data Management Services 79

6.8 Clinical Trial Supply & Logistic Services 80

6.9 Decentralized Clinical Trial Services 81

6.10 Medical Device Testing Services 82

6.11 Other Clinical Trial Services 83

7 Segmentation of Europe Market by Indication 84

7.1 Market Overview by Indication 84

7.2 Oncology 86

7.3 Infectious Diseases 87

7.4 Cardiology 88

7.5 Obesity 89

7.6 Diabetes 90

7.7 Neurology 91

7.8 Immunology 92

7.9 Pain Management 93

7.10 Other Indications 94

8 Segmentation of Europe Market by End User 95

8.1 Market Overview by End User 95

8.2 Pharmaceutical and Biotechnological Companies 97

8.3 Clinical Research Organizations 98

8.4 Clinical Testing Laboratories 99

8.5 Other End Users 100

9 European Market 2021-2031 by Country 101

9.1 Overview of European Market 101

9.2 Germany 104

9.3 U.K. 106

9.4 France 108

9.5 Spain 110

9.6 Italy 112

9.7 Russia 114

9.8 Rest of European Market 116

10 Competitive Landscape 118

10.1 Overview of Key Vendors 118

10.2 New Product Launch, Partnership, Investment, and M&A 122

10.3 Company Profiles 123

Accell Clinical Research LLC 123

Charles River Laboratory 125

ClinDatrix Inc 126

Clinipace 127

Eli Lilly and Company 128

F. Hoffmann-La Roche Ltd. 129

ICON PLC 130

IQVIA Holdings, Inc. 131

Laboratory Corporation of America 132

Novo Nordisk AS 133

PAREXEL International Corporation 134

Pfizer Inc. 135

Pharmaceutical Product Development LLC 136

PRA Health Sciences 137

Sanofi SA 138

SGS SA 139

Syneos Health Inc. 140

Wuxi AppTec Inc. 141

RELATED REPORTS 142

List of Tables:

Table 1. Snapshot of Europe Clinical Trials Market in Balanced Perspective, 2021-2031 17
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021 20
Table 3. World Economic Outlook, 2021-2031 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in Europe Clinical Trials Market 35
Table 6. Europe Clinical Trials Market by Product Category, 2021-2031, $ mn 43
Table 7. Europe Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn 45
Table 8. Europe Clinical Trials Market by Phase, 2021-2031, $ mn 52
Table 9. Europe Clinical Trials Market by Design, 2021-2031, $ mn 58
Table 10. Europe Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn 61
Table 11. Europe Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn 66
Table 12. Europe Clinical Trials Market by Service Type, 2021-2031, $ mn 72
Table 13. Europe Clinical Trials Market by Indication, 2021-2031, $ mn 84
Table 14. Europe Clinical Trials Market by End User, 2021-2031, $ mn 95
Table 15. Europe Clinical Trials Market by Country, 2021-2031, $ mn 103
Table 16. Germany Clinical Trials Market by Phase, 2021-2031, $ mn 105
Table 17. Germany Clinical Trials Market by Design, 2021-2031, $ mn 105
Table 18. Germany Clinical Trials Market by Indication, 2021-2031, $ mn 105
Table 19. U.K. Clinical Trials Market by Phase, 2021-2031, $ mn 107
Table 20. U.K. Clinical Trials Market by Design, 2021-2031, $ mn 107
Table 21. U.K. Clinical Trials Market by Indication, 2021-2031, $ mn 107
Table 22. France Clinical Trials Market by Phase, 2021-2031, $ mn 109
Table 23. France Clinical Trials Market by Design, 2021-2031, $ mn 109
Table 24. France Clinical Trials Market by Indication, 2021-2031, $ mn 109
Table 25. Spain Clinical Trials Market by Phase, 2021-2031, $ mn 111
Table 26. Spain Clinical Trials Market by Design, 2021-2031, $ mn 111
Table 27. Spain Clinical Trials Market by Indication, 2021-2031, $ mn 111
Table 28. Italy Clinical Trials Market by Phase, 2021-2031, $ mn 113
Table 29. Italy Clinical Trials Market by Design, 2021-2031, $ mn 113
Table 30. Italy Clinical Trials Market by Indication, 2021-2031, $ mn 113
Table 31. Russia Clinical Trials Market by Phase, 2021-2031, $ mn 115
Table 32. Russia Clinical Trials Market by Design, 2021-2031, $ mn 115
Table 33. Russia Clinical Trials Market by Indication, 2021-2031, $ mn 115
Table 34. Clinical Trials Market in Rest of Europe by Country, 2021-2031, $ mn 117
Table 35. Percentage of Registered Studies by Location (as of February 24, 2022) 120
Table 36. Percentage of Recruiting Studies by Location (as of February 24, 2022) 120
Table 37. Accell Clinical Research LLC: Company Snapshot 123
Table 38. Accell Clinical Research LLC: Business Segmentation 124
Table 39. Accell Clinical Research LLC: Product Portfolio 124

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Europe Clinical Trials Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Europe Clinical Trials Market 25
Figure 7. Percentage of Trial Participants by Country, 2015-2019 28
Figure 8. Leading Causes of Death in the World, 2019-2020, million 29
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 11. Primary Restraints and Impact Factors of Europe Clinical Trials Market 32
Figure 12. Investment Opportunity Analysis 36
Figure 13. Porter’s Fiver Forces Analysis of Europe Clinical Trials Market 39
Figure 14. Breakdown of Europe Clinical Trials Market by Product Category, 2021-2031, % of Revenue 44
Figure 15. Europe Addressable Market Cap in 2022-2031 by Product Category, Value ($ mn) and Share (%) 44
Figure 16. Europe Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn 45
Figure 17. Europe Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn 46
Figure 18. Europe Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn 47
Figure 19. Europe Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn 48
Figure 20. Europe Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn 49
Figure 21. Europe Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn 50
Figure 22. Europe Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn 51
Figure 23. Breakdown of Europe Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue 53
Figure 24. Europe Addressable Market Cap in 2022-2031 by Phase, Value ($ mn) and Share (%) 53
Figure 25. Europe Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn 54
Figure 26. Europe Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn 55
Figure 27. Europe Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn 56
Figure 28. Europe Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn 57
Figure 29. Breakdown of Europe Clinical Trials Market by Design, 2021-2031, % of Sales Revenue 59
Figure 30. Europe Addressable Market Cap in 2022-2031 by Design, Value ($ mn) and Share (%) 59
Figure 31. Europe Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn 60
Figure 32. Europe Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn 62
Figure 33. Europe Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn 63
Figure 34. Europe Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn 64
Figure 35. Europe Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn 65
Figure 36. Europe Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn 67
Figure 37. Europe Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn 68
Figure 38. Europe Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn 69
Figure 39. Europe Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn 70
Figure 40. Europe Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn 71
Figure 41. Breakdown of Europe Clinical Trials Market by Service Type, 2021-2031, % of Revenue 73
Figure 42. Europe Addressable Market Cap in 2022-2031 by Service Type, Value ($ mn) and Share (%) 73
Figure 43. Europe Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn 74
Figure 44. Europe Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn 75
Figure 45. Europe Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn 76
Figure 46. Europe Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn 77
Figure 47. Europe Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn 78
Figure 48. Europe Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn 79
Figure 49. Europe Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn 80
Figure 50. Europe Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn 81
Figure 51. Europe Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn 82
Figure 52. Europe Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn 83
Figure 53. Breakdown of Europe Clinical Trials Market by Indication, 2021-2031, % of Revenue 85
Figure 54. Europe Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 85
Figure 55. Europe Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn 86
Figure 56. Europe Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn 87
Figure 57. Europe Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn 88
Figure 58. Europe Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn 89
Figure 59. Europe Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn 90
Figure 60. Europe Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn 91
Figure 61. Europe Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn 92
Figure 62. Europe Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn 93
Figure 63. Europe Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn 94
Figure 64. Breakdown of Europe Clinical Trials Market by End User, 2021-2031, % of Revenue 95
Figure 65. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 96
Figure 66. Europe Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn 97
Figure 67. Europe Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn 98
Figure 68. Europe Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn 99
Figure 69. Europe Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn 100
Figure 70. Breakdown of European Clinical Trials Market by Country, 2021 and 2031, % of Revenue 102
Figure 71. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 103
Figure 72. Clinical Trials Market in Germany, 2021-2031, $ mn 104
Figure 73. Clinical Trials Market in U.K., 2021-2031, $ mn 106
Figure 74. Clinical Trials Market in France, 2021-2031, $ mn 108
Figure 75. Clinical Trials Market in Spain, 2021-2031, $ mn 110
Figure 76. Clinical Trials Market in Italy, 2021-2031, $ mn 112
Figure 77. Clinical Trials Market in Russia, 2021-2031, $ mn 114
Figure 78. Clinical Trials Market in Rest of Europe, 2021-2031, $ mn 116
Figure 79. Growth Stage of Europe Clinical Trials Industry over the Forecast Period 118

Interested in this report?
Get your FREE sample!

Safe and Secure SSl Encryption

Licensing options

3200
USD

Single User License
Site License
Global User License

How client has rates us?

Requirement Gathering & Methodology

Data Collection Techniques

Our Research Team & Data Sourcing

Data Science & Analytical Tools

Data Visualization & Presentation Skills

Project/ Report Delivery & After Sales Services

Testimonial

READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.

PRODUCT DEVELOPMENT MANAGER

CEO

Vivek Arora

BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!

EXECUTIVE DIRECTOR

Rahul Roy

THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.

SALES DIRECTOR

Arjun Prasad

THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH

MARKETING MANAGER

President

Manish Verma

Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

MARKETING DIRECTOR

Gautam Saxena

The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.

PRODUCT MANAGER

Tom Stone

I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.

Associate Director

Mark Wood

Europe Clinical Trials Market 2021-2031

Europe Clinical Trials Market 2021-2031